Navigation Links
EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino
Date:11/11/2010

EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino -- BOSTON, November 11, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Internet Technology, Multimedia & Internet, Web Site, Biotechnology, Medical Pharmaceuticals, Pharmaceuticals, Corporate Expansion Click to view news release full screen  

EvaluatePharma USA, Inc. Welcomed Into Boston Biotech Community by Mayor Menino

 

BOSTON, November 11, 2010 /PRNewswire/ -- EvaluatePharma USA, Inc. the online analysis service for the global biotechnology and pharmaceutical sector, was welcomed into Boston's biotech community today by Mayor Menino at the opening of their new office in Boston, the #1 life sciences cluster in the US.

Senior Vice President Debbie Paul said, "EvaluatePharma USA are very excited to be joining the Boston biotech community with the opening of our new office at Broad Street. Many of our clients are based in Boston and we will now be able to work more closely with the biotech community, supporting them with innovative products and services designed to help the commercialization of their products."

Commenting at the opening ceremony, Dr. Jonathan de Pass, CEO and Founder said "We are very grateful to Mayor Menino and the LifeTech programme for their help and support in the opening of this new office. EvaluatePharma is committed to developing new products and services that continue to support the biotech community such as the launch of our new service Partnering Opportunities. By registering their licensing assets with our Partnering Opportunities the biotech community can reach our global audience of business development and licensing professionals across the world's leading pharma companies."

EvaluatePharma's Partnering Opportunities is a new free service that allows potential partners to see the latest opportunities from the biotech community in their commercial context alongside EvaluatePharma's industry analysis, including product portfolios, company financials and reference deal terms.

Founded in 1996 by Dr. Jonathan de Pass, a former top-ranked Pharmaceutical analyst in the City of London, EvaluatePharma(R) provides proprietary insights into the commercial and financial prospects of the pharma and biotech industry and was the first company to provide reliable consensus forecasts of global drug sales. Analyses range from total market sales trends and therapeutic overviews to individual company financial performance and product progress.

EvaluatePharma's client base includes the top global pharma and biotech companies, the investment banking community and the leading global management consulting firms.

Notes to editors

About EvaluatePharma:

The research company EvaluatePharma was the first to supply reliable consensus forecasts of global drug sales and now provides standardised worldwide financial and forecast models with consensus product sales forecasts to 2016, data on R&D pipelines, licensing deals, patent risk and M&A activity. Launched in 2007, EvaluatePharma(R)Alpha offers a Net Present Value (NPV) valuation service quantifying market events and the impact on product, portfolio and company valuation including the daily online news service EP Vantage(R).

EvaluatePharma(R), EvaluatePharma(R)Alpha, and EP Vantage(R) are services of EvaluatePharma Ltd, headquartered in London, England. In North America, EvaluatePharma Ltd is represented by

EvaluatePharma USA, Inc. http://www.evaluatepharma.com Contact: Debbie Paul Senior Vice President, North America T: +1-866-806-1309 E: debbiep@evaluatepharma.com EvaluatePharma USA, Inc. 15 Broad Street, Suite 401 Boston, MA 02109 USA Andrew Beaven Marketing Director, EvaluatePharma Ltd T: +44(0)20-7539-1818 E: andrewb@evaluatepharma.com EvaluatePharma Ltd 11-29 Fashion Street London E1 6PX United Kingdom
'/>"/>

SOURCE EvaluatePharma Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SIGVARIS Provides Red Socks to Honor Efforts by Boston Red Sox Manager, Terry Francona, to Raise Awareness for DVT Prevention
2. PAREXEL International to Participate in the Lazard Capital Markets Healthcare Conference in New York and the Jefferies Healthcare Summit in Boston
3. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
4. Boston Scientific Completes Acquisition of Asthmatx
5. Boston Scientific Announces CE Mark Approval for Expanded Indication of WallFlex® Biliary RX Stent
6. Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents
7. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
8. Boston Scientific Announces Global Launch of Journey™ Guidewire
9. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
10. Boston Scientific Welcomes Publication of Analysis Demonstrating Long-Term Survival Benefit for ICD Therapy
11. Boston Scientifics TAXUS® Element™ Stent Demonstrates Strong Outcomes in Diabetic Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)... -- Commended for their devotion to personalized service, SMP Pharmacy Solutions ... in the South Florida Business Journal,s 50 Fastest-Growing Companies, and ... the national specialty pharmacy has found its niche.  To that ... be honored by SFBJ as the 2017 Power Leader in ... receive his award in October, Bardisa said of the three ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... Little Rock, AR (PRWEB) , ... October 13, ... ... owned firm with locations throughout Arkansas that offers insurance and financial preparation services, ... to benefit the Rock City Rescue organization. , Rock City Rescue is a ...
(Date:10/13/2017)... ... 2017 , ... PurhealthRX , a leading Health and Nutrition Company, is ... to full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing ... easily incorporated into liquid products, while reducing costs to end users. , The team ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
Breaking Medicine News(10 mins):